We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
NMC
1
NEA Management Company
Maryland
$54M
MCMC
2
Matrix Capital Management Company
New Hampshire
$39M +$45.4M +8,692,083 New
Capital World Investors
3
Capital World Investors
California
$30.5M
Fidelity Investments
4
Fidelity Investments
Massachusetts
$23.6M -$5.33M -1,019,900 -16%
O
5
OrbiMed
New York
$8.6M
TCM
6
Tekla Capital Management
Massachusetts
$6.58M
Baillie Gifford & Co
7
Baillie Gifford & Co
United Kingdom
$5.94M +$2.1M +402,324 +44%
QF
8
QVT Financial
New York
$5.66M
HIM
9
Hillhouse Investment Management
Cayman Islands
$5.34M
Renaissance Technologies
10
Renaissance Technologies
New York
$4.8M +$1.51M +288,500 +37%
RSCM
11
Rock Springs Capital Management
Maryland
$3.93M
Axa
12
Axa
France
$3.9M -$170K -32,539 -4%
Fidelity International
13
Fidelity International
Bermuda
$3.38M
Wellington Management Group
14
Wellington Management Group
Massachusetts
$2.54M -$220K -42,080 -7%
Point72 Asset Management
15
Point72 Asset Management
Connecticut
$2.45M +$116K +22,200 +4%
Adage Capital Partners
16
Adage Capital Partners
Massachusetts
$2.06M -$131K -25,000 -5%
AG
17
Artal Group
Luxembourg
$1.35M
Deutsche Bank
18
Deutsche Bank
Germany
$1.13M +$724K +138,519 +122%
A
19
Abingworth
United Kingdom
$1.13M
Millennium Management
20
Millennium Management
New York
$1.11M -$2.47M -472,226 -66%
VIA
21
Vident Investment Advisory
Georgia
$1.09M +$56.9K +10,894 +5%
RG
22
Rathbones Group
United Kingdom
$900K
EIM
23
Essex Investment Management
Massachusetts
$862K +$791K +151,273 +371%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$846K +$985K +188,487 New
GIP
25
Granite Investment Partners
California
$838K -$47K -8,993 -5%